Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Poisson Probability Distribution01:09

Poisson Probability Distribution

A Poisson probability distribution is a discrete probability distribution. It gives the probability of a number of events occurring in a fixed interval of time or space if these events happen at a known average rate and independently of the time since the last event. For example, a book editor might be interested in the number of words spelled incorrectly in a particular book. It might be that, on average, there are five words spelled incorrectly in 100 pages. The interval is 100 pages.
The...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Noncompartmental Analysis: Mean Residence Time01:05

Noncompartmental Analysis: Mean Residence Time

According to statistical moment theory, mean residence time (MRT) is an important measure in pharmacokinetics. MRT can be defined as the expected mean of a probability density function distribution. It provides valuable insights into drug disposition in the body.
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Quadratic Programming to Reconstruct Data From Published Survival and Competing Risks Analyses.

Statistics in medicine·2026
Same author

Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for a prospective multicentre case-control study.

BMJ open·2025
Same author

Comparison of outcomes after living and deceased donor kidney transplantation: UK national cohort study.

The British journal of surgery·2025
Same author

Non-invasive breath testing to detect colorectal cancer: protocol for a multicentre, case-control development and validation study (COBRA2 study).

BMC cancer·2025
Same author

Development of START-EDI guidelines for reporting equality, diversity and inclusion in research: a study protocol.

BMJ open·2025
Same author

Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysis.

Annals of internal medicine·2025

Related Experiment Video

Updated: Jun 18, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Semi-Markov models with phase-type sojourn distributions.

Andrew C Titman1, Linda D Sharples

  • 1Department of Mathematics and Statistics, Lancaster University, Lancaster, UK.
a.titman@lancaster.ac.uk

Biometrics
|November 17, 2009
PubMed
Summary
This summary is machine-generated.

This study introduces a new semi-Markov model for chronic disease progression, improving analysis of data observed at discrete time points. The phase-type sojourn distribution simplifies computation for complex disease state transitions.

More Related Videos

C. elegans Tracking and Behavioral Measurement
07:36

C. elegans Tracking and Behavioral Measurement

Published on: November 17, 2012

Related Experiment Videos

Last Updated: Jun 18, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

C. elegans Tracking and Behavioral Measurement
07:36

C. elegans Tracking and Behavioral Measurement

Published on: November 17, 2012

Area of Science:

  • Biostatistics
  • Epidemiology
  • Medical Statistics

Background:

  • Continuous-time multistate models are crucial for analyzing chronic disease progression but face inference challenges with discrete observations.
  • The standard Markov assumption, where transition rates are independent of time in state, can be overly simplistic for chronic diseases.
  • Semi-Markov models offer a more flexible approach by allowing transition rates to depend on time spent in the current state.

Purpose of the Study:

  • To address computational difficulties in fitting semi-Markov models to panel-observed data.
  • To present a novel class of semi-Markov models utilizing phase-type sojourn distributions.
  • To extend the methodology to accommodate classification errors in observed disease states.

Main Methods:

  • Development of semi-Markov models incorporating phase-type sojourn distributions.
  • Application of hidden Markov model techniques to the proposed semi-Markov framework.
  • Demonstration of the methodology using real-world data on bronchiolitis obliterans syndrome.

Main Results:

  • The proposed phase-type semi-Markov models significantly alleviate computational challenges in analyzing discrete-time panel data.
  • The methodology effectively handles complex disease state transitions where time in state influences progression rates.
  • The approach was successfully applied to model bronchiolitis obliterans syndrome in lung transplant recipients.

Conclusions:

  • Phase-type semi-Markov models provide a computationally feasible and flexible framework for analyzing chronic disease data observed at discrete intervals.
  • This methodology enhances the understanding of disease dynamics, particularly when transition rates are time-dependent.
  • The approach offers valuable insights for managing chronic conditions and improving patient outcomes, as demonstrated in the lung transplant example.